Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants

Adel A. ElHennawy, John W. Sparks, Debra Armentrout, Valerie Huseby, Carol Lynn Berseth

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: Approximately half of extremely low birth weight infants have feeding intolerance, which delays their achievement of full enteral feedings. Erythromycin, a motilin receptor agonist, triggers migrating motor complexes and accelerates gastric emptying in adults with feeding intolerance. Few studies have assessed the efficacy of this drug in preterm infants with established feeding intolerance. This study was designed to assess the efficacy of erythromycin in feeding-intolerant infants, as measured by gastric emptying, maturation of gastrointestinal motor patterns, and time to achieve full enteral feedings. Methods: Subjects were 27 preterm infants who were admitted to the neonatal intensive care unit and who did not achieve full enteral feeding volumes (150 mL/kg/day) within 8 days of the initiation of feedings. In a controlled, randomized, double-blinded clinical trial, infants received intragastric erythromycin or placebo for 8 days without crossover. At study entry, the authors recorded motor activity in the antrum and the duodenum during fasting, in response to intragastric erythromycin (1.5 mg/kg) or placebo, and in response to feeding. Gastric emptying at 20 minutes and transit time from duodenum to anus were determined. Each infant then received erythromycin or placebo for 8 days, and feeding characteristics were prospectively tracked. Results: Gastric emptying and characteristics of antroduodenal motor contractions were similar in the two groups, as were the transit times from duodenum to anus. Feeding outcomes were comparable in the two groups. Conclusion: Intragastric erythromycin does not improve feeding tolerance in preterm infants with established feeding intolerance because it fails to improve gastrointestinal function in the short or long term.

Original languageEnglish (US)
Pages (from-to)281-286
Number of pages6
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume37
Issue number3
DOIs
StatePublished - Sep 2003
Externally publishedYes

Fingerprint

erythromycin
Erythromycin
Premature Infants
gastric emptying
Gastric Emptying
enteral feeding
Enteral Nutrition
duodenum
Duodenum
placebos
infant feeding
anus
Placebos
Anal Canal
Extremely Low Birth Weight Infant
Migrating Myoelectric Complexes
low birth weight
Neonatal Intensive Care Units
agonists
fasting

Keywords

  • Feeding intolerance
  • Gastric emptying
  • Intestinal motility
  • Preterm infants
  • Prokinetic

ASJC Scopus subject areas

  • Gastroenterology
  • Histology
  • Medicine (miscellaneous)
  • Food Science
  • Pediatrics, Perinatology, and Child Health

Cite this

Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants. / ElHennawy, Adel A.; Sparks, John W.; Armentrout, Debra; Huseby, Valerie; Berseth, Carol Lynn.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 37, No. 3, 09.2003, p. 281-286.

Research output: Contribution to journalArticle

ElHennawy, Adel A. ; Sparks, John W. ; Armentrout, Debra ; Huseby, Valerie ; Berseth, Carol Lynn. / Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants. In: Journal of Pediatric Gastroenterology and Nutrition. 2003 ; Vol. 37, No. 3. pp. 281-286.
@article{b6014dc45f06480fbb9f8bf1fc71192b,
title = "Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants",
abstract = "Objective: Approximately half of extremely low birth weight infants have feeding intolerance, which delays their achievement of full enteral feedings. Erythromycin, a motilin receptor agonist, triggers migrating motor complexes and accelerates gastric emptying in adults with feeding intolerance. Few studies have assessed the efficacy of this drug in preterm infants with established feeding intolerance. This study was designed to assess the efficacy of erythromycin in feeding-intolerant infants, as measured by gastric emptying, maturation of gastrointestinal motor patterns, and time to achieve full enteral feedings. Methods: Subjects were 27 preterm infants who were admitted to the neonatal intensive care unit and who did not achieve full enteral feeding volumes (150 mL/kg/day) within 8 days of the initiation of feedings. In a controlled, randomized, double-blinded clinical trial, infants received intragastric erythromycin or placebo for 8 days without crossover. At study entry, the authors recorded motor activity in the antrum and the duodenum during fasting, in response to intragastric erythromycin (1.5 mg/kg) or placebo, and in response to feeding. Gastric emptying at 20 minutes and transit time from duodenum to anus were determined. Each infant then received erythromycin or placebo for 8 days, and feeding characteristics were prospectively tracked. Results: Gastric emptying and characteristics of antroduodenal motor contractions were similar in the two groups, as were the transit times from duodenum to anus. Feeding outcomes were comparable in the two groups. Conclusion: Intragastric erythromycin does not improve feeding tolerance in preterm infants with established feeding intolerance because it fails to improve gastrointestinal function in the short or long term.",
keywords = "Feeding intolerance, Gastric emptying, Intestinal motility, Preterm infants, Prokinetic",
author = "ElHennawy, {Adel A.} and Sparks, {John W.} and Debra Armentrout and Valerie Huseby and Berseth, {Carol Lynn}",
year = "2003",
month = "9",
doi = "10.1097/00005176-200309000-00015",
language = "English (US)",
volume = "37",
pages = "281--286",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants

AU - ElHennawy, Adel A.

AU - Sparks, John W.

AU - Armentrout, Debra

AU - Huseby, Valerie

AU - Berseth, Carol Lynn

PY - 2003/9

Y1 - 2003/9

N2 - Objective: Approximately half of extremely low birth weight infants have feeding intolerance, which delays their achievement of full enteral feedings. Erythromycin, a motilin receptor agonist, triggers migrating motor complexes and accelerates gastric emptying in adults with feeding intolerance. Few studies have assessed the efficacy of this drug in preterm infants with established feeding intolerance. This study was designed to assess the efficacy of erythromycin in feeding-intolerant infants, as measured by gastric emptying, maturation of gastrointestinal motor patterns, and time to achieve full enteral feedings. Methods: Subjects were 27 preterm infants who were admitted to the neonatal intensive care unit and who did not achieve full enteral feeding volumes (150 mL/kg/day) within 8 days of the initiation of feedings. In a controlled, randomized, double-blinded clinical trial, infants received intragastric erythromycin or placebo for 8 days without crossover. At study entry, the authors recorded motor activity in the antrum and the duodenum during fasting, in response to intragastric erythromycin (1.5 mg/kg) or placebo, and in response to feeding. Gastric emptying at 20 minutes and transit time from duodenum to anus were determined. Each infant then received erythromycin or placebo for 8 days, and feeding characteristics were prospectively tracked. Results: Gastric emptying and characteristics of antroduodenal motor contractions were similar in the two groups, as were the transit times from duodenum to anus. Feeding outcomes were comparable in the two groups. Conclusion: Intragastric erythromycin does not improve feeding tolerance in preterm infants with established feeding intolerance because it fails to improve gastrointestinal function in the short or long term.

AB - Objective: Approximately half of extremely low birth weight infants have feeding intolerance, which delays their achievement of full enteral feedings. Erythromycin, a motilin receptor agonist, triggers migrating motor complexes and accelerates gastric emptying in adults with feeding intolerance. Few studies have assessed the efficacy of this drug in preterm infants with established feeding intolerance. This study was designed to assess the efficacy of erythromycin in feeding-intolerant infants, as measured by gastric emptying, maturation of gastrointestinal motor patterns, and time to achieve full enteral feedings. Methods: Subjects were 27 preterm infants who were admitted to the neonatal intensive care unit and who did not achieve full enteral feeding volumes (150 mL/kg/day) within 8 days of the initiation of feedings. In a controlled, randomized, double-blinded clinical trial, infants received intragastric erythromycin or placebo for 8 days without crossover. At study entry, the authors recorded motor activity in the antrum and the duodenum during fasting, in response to intragastric erythromycin (1.5 mg/kg) or placebo, and in response to feeding. Gastric emptying at 20 minutes and transit time from duodenum to anus were determined. Each infant then received erythromycin or placebo for 8 days, and feeding characteristics were prospectively tracked. Results: Gastric emptying and characteristics of antroduodenal motor contractions were similar in the two groups, as were the transit times from duodenum to anus. Feeding outcomes were comparable in the two groups. Conclusion: Intragastric erythromycin does not improve feeding tolerance in preterm infants with established feeding intolerance because it fails to improve gastrointestinal function in the short or long term.

KW - Feeding intolerance

KW - Gastric emptying

KW - Intestinal motility

KW - Preterm infants

KW - Prokinetic

UR - http://www.scopus.com/inward/record.url?scp=1542681454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542681454&partnerID=8YFLogxK

U2 - 10.1097/00005176-200309000-00015

DO - 10.1097/00005176-200309000-00015

M3 - Article

C2 - 12960650

AN - SCOPUS:1542681454

VL - 37

SP - 281

EP - 286

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 3

ER -